PredictImmune: James Clark

PredictImmune has appointed James Clark as its chief technology officer.

Clark was previously CEO of EnteroBiotix, a developer of microbiome modulating therapeutics.

Prior to his work at EnteroBiotix, he was vice president of clinical laboratory operations at Inivata, chief technology officer at Enterome, vice president of research and development at MDxHealth, and chief operating officer at Response Genetics.